ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
19.00
Bid
18.55
Ask
19.10
Volume
5,668
18.55 Day's Range 19.50
16.30 52 Week Range 21.90
Market Cap
Previous Close
19.10
Open
19.50
Last Trade
878
@
19.1
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
8,290
Shares Outstanding
40,397,605
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
25.12M
Net Profit
-6.16M

About Philogen Spa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Siena, Siena, Ita
Founded
-
Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 19.10 €. Over the last year, Philogen shares have traded in a share price range of 16.30 € to 21.90 €.

Philogen currently has 40,397,605 shares outstanding. The market capitalization of Philogen is 771.59 € million.

PHIL Latest News

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

Philogen Announces Clinical Trial Collaboration with MSD

Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with...

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand Mumbai...

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich Philogen Publishes New Data on a...

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology Philogen Announces Publication...

Philogen Provides Corporate Update

Philogen Provides Corporate Update Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.351.8766756032218.6519.7518.05483918.59734047DE
4-0.95-4.761904761919.952018.05605619.02868083DE
12-1.1-5.4726368159220.121.318.05829019.73256531DE
26-1.3-6.403940886720.321.918.05651220.08872547DE
520.94.9723756906118.121.916.3869719.02855775DE
1564.9835.520684736114.0221.913881716.77987179DE
260211.76470588241721.912.61217216.01515378DE

PHIL - Frequently Asked Questions (FAQ)

What is the current Philogen share price?
The current share price of Philogen is 19.00 €
How many Philogen shares are in issue?
Philogen has 40,397,605 shares in issue
What is the market cap of Philogen?
The market capitalisation of Philogen is EUR 771.59M
What is the 1 year trading range for Philogen share price?
Philogen has traded in the range of 16.30 € to 21.90 € during the past year
What is the reporting currency for Philogen?
Philogen reports financial results in EUR
What is the latest annual turnover for Philogen?
The latest annual turnover of Philogen is EUR 25.12M
What is the latest annual profit for Philogen?
The latest annual profit of Philogen is EUR -6.16M
What is the registered address of Philogen?
The registered address for Philogen is PIAZZA LA LIZZA, 7, SIENA, SIENA, 53100
What is the Philogen website address?
The website address for Philogen is www.philogen.com
Which industry sector does Philogen operate in?
Philogen operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WFTC26Finanzatech Spa
0.025 €
(26.26%)
40
WART28DeodatoGallery SpA
0.0558 €
(24.00%)
27.4k
WFAE25Fae Technology
0.50 €
(16.23%)
20
WSGC28SG Company SpA
0.0294 €
(13.51%)
1,000
WPOZ27Pozzi Milano Spa
0.102 €
(13.33%)
14.05k
WPSQ26Pasquarelli Auto SpA
0.0109 €
(-44.10%)
923
1CDECoeur Mining Inc
5.51 €
(-20.63%)
500
1WCHWacker Chemie AG
67.50 €
(-18.28%)
218
WTFINTrevi Finanziaria Industriale Spa
1.011 €
(-17.54%)
2.42k
EPHEPH SpA
0.1002 €
(-16.50%)
6.72k
TITTelecom Italia SpA
0.243 €
(-3.19%)
370.41M
ISPIntesa Sanpaolo Spa
3.841 €
(-0.31%)
137.21M
SPMSaipem Spa
2.484 €
(-6.02%)
64.72M
TITRTelecom Italia
0.2813 €
(-3.10%)
47.53M
ENELEnel Spa
6.804 €
(0.04%)
42.28M

Discussion

View Full Feed
Golden Cross Golden Cross 9 minutes ago
$ILLR 📺Triller TV – Shaping the Future of Live Digital Sports

~ Triller TV is redefining how we watch, experience, and engage with digital sports.

https://www.youtube.com/watch?v=VA7L-C3OAnM
ILLR
ranger_7 ranger_7 10 minutes ago
It sure seems like it. 
IBGR
Golden Cross Golden Cross 10 minutes ago
$ILLR 📺Triller TV – Shaping the Future of Live Digital Sports

~ Triller TV is redefining how we watch, experience, and engage with digital sports.

https://www.youtube.com/watch?v=VA7L-C3OAnM
ILLR
WiseYoda WiseYoda 14 minutes ago
style="font-size: 1em"Bitstamp is building a derivatives exchange on the XRP Ledger and being acquired by Robinhood in 2025.  style="font-size: 1em"XRP is moon bound! 
XRPUSD
Tahoe2468 Tahoe2468 14 minutes ago

If I'm lying I'm dying.... 🚀🚀🚀🚀🚀🚀🚀
TNXP
rx7171 rx7171 21 minutes ago
“In press”
The publication is announcing the article has been reviewed and is accepted for publication.
AVXL
fuagf fuagf 21 minutes ago
When someone claims something they have virtually no evidence for then something is missing. Something
more than the evidence to justify the claim. Especially when virtually no experts in the field agree with you.
mrfence mrfence 24 minutes ago
Hi Kt.
FNMA
elks elks 27 minutes ago
Boom time coming
WNFT
axelvento axelvento 28 minutes ago
Trump Is Right About The Polio Vaccine: An American Triumph

https://www.forbes.com/sites/globalcitizen/2024/12/19/the-polio-vaccine-a-victory-of-american-spirit-trump-can-stand-behind/
MRNA
The Man With No Name The Man With No Name 29 minutes ago
Dishonest because you are uninformed or ignorant, whichever applies. You and your buddy need to go file your lawsuits and learn the hard way.
FNMA
mrfence mrfence 30 minutes ago
Waterstone did a massive naked short before the seizure and before Reg Sho. Most of the Valuewalk article links covering the short in detail have been scrubbed. I recall the implication is they're short more shares than are issued. Many heavy shorts occurred post seizure too assuming FnF would be un
FNMA
Genz2 Genz2 30 minutes ago
https://www.wifr.com/2024/12/20/schnucks-donates-200k-salvation-army-after-round-up-register-campaign/

That is so NICE to see!! I used to go into this one store where you could round up and that donation would go to charity!! They stopped doing it, but it seems like that was a good
Calvin Hobbes Calvin Hobbes 34 minutes ago
$GGSM I bought 8's on that PR and NEW X account. I can see the potential here for 2025. I don't think they would have did that (CREATED NEW X ACCOUNT) if they did not intend on communicating with shareholders.
How can anyone front load?
The price was the lowest it has been for a whil
GGSM
RichieBoy RichieBoy 36 minutes ago
True that, but we do know we're being hedged like hell.

So I'm anticipating AFFU newbs will come to there senses over the weekend realizing there's absolutely no rational reason to be feeding anyone there shares. Could be wrong, I haven't taken a good look at next week's market hours
AFFU
Evergreen Plateau Evergreen Plateau 38 minutes ago
GGSM .0008 8.6 million revenue for 9 month 2024 per recent press release
New president $$$ Todd Noble
2 billion os... cash on hand
Book value.005 -.007
GGSM
Matt24777 Matt24777 42 minutes ago
Hello RSI,

MERRY CHRISTMAS AND A HAPPY NEW YEAR TO YOU AND YOUR FAMILY. 
PLYZ
Researchfyi Researchfyi 43 minutes ago
Another week passes and LQMT’s share price is down 4.18% from 0.043 cents to 0.0412 cents on extremely weak trading volumes and little interest. The same when LQMT moves up or down.

The share price remains in a coma like the new contracts anticipated for almost three years now, due t
LQMT
Evergreen Plateau Evergreen Plateau 44 minutes ago
GGSM

https://investorshub.advfn.com/Micro-Penny-Value-Growth-Shares-OTCBB-6982
GGSM
RichieBoy RichieBoy 45 minutes ago
Oh ok thank you, you're most welcome.

Merry Christmas🎄
AFFU
newmedman newmedman 48 minutes ago
The only thing missing was the santa hat lol.

[yt]TQXuazYI_YU[/yt]
Evergreen Plateau Evergreen Plateau 50 minutes ago
GGSM .0008
Name change in the future imo
Recently a change in director Todd Noble
Is president
Recently pr reflects significant revenue for a trip stock .. 9 month 8.6 mill revenue
Also strong cash position per filing
Need audited fins
Os around
GGSM
ignatiusrielly35 ignatiusrielly35 51 minutes ago
As I advised last week, there was zero chance that the imaginary mm manipulators would allow the call options at $9 and above to be ITM. 

There are no more weeklies, for whatever reason, so you have another month.
AVXL
GoodGuyBill GoodGuyBill 52 minutes ago
Settlement?
NWBO
Louinjaxxx Louinjaxxx 52 minutes ago
So you want them to reveal competition sensitive information?  Good luck with that.
AXXA

Your Recent History

Delayed Upgrade Clock